Logo
E

Evommune

24 employees

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Chronic Disease
Life Science
Research and Development
Health Care
Patient Care
Inflammatory Disease
Medicines

Date founded

2020

Funding rounds raised

Total raised

$83M

from 7 investors over 7 rounds

E

Evommune raised $50M on April 26, 2023

Investors: Arix Bioscience plc, Amplitude Ventures, Andera Partners, SymBiosis and EQT Life Sciences

E

Evommune raised $83M on September 9, 2021

Investors: Andera Partners and LSP (Life Sciences Partners)

FAQ